Köhler H, Kirch W, Pitz H
Klin Wochenschr. 1978 Oct 1;56(19):977-83. doi: 10.1007/BF01480153.
6 patients without evidence for renal, hepatic or pancreatic disease were treated with intravenous infusions of 500 ml hydroxyethyl starch (6%) over a period of 60 min. In the course of the infusion we observed an increase in plasma volume from 2.72 +/- 0.101 to 3.36 +/- 0.141. After 2 h plasma volume decreased to 3.02 +/- 0.101 but showed a second peak of 3.23 +/- 0.121 after 4 h (p less than 0.01). 24 h following infusion an increase in plasma volume of 4,8% was found as compared to preinfusion values. The second increase in plasma volume cannot be explained by the total concentration of hydroxyethyl starch since the latter decreased continuously. The increase in plasma volume was accompanied by a decrease in average molecular weight (-Mw and -Mn). It is suggested that serum amylase produces small osmotic active molecules by degradation of hydroxyethyl starch, thus leading to an increase in plasma volume. 12--24 h after the infusion of hydroxyethyl starch serum amylase was more than twice as high basal values. This is caused by the formation of a high molecular hydroxyethyl starch-amylase-complex which cannot be eliminated easily. When hydroxyethyl starch is given repeatedly to normovolemic patients, the second increase in plasma volume should be considered as a possible cause for acute hypervolemia. This is especially true for patients with myocardial insufficiency.
6例无肾脏、肝脏或胰腺疾病证据的患者接受了60分钟内静脉输注500毫升羟乙基淀粉(6%)的治疗。在输注过程中,我们观察到血浆容量从2.72±0.101增加到3.36±0.141。2小时后血浆容量降至3.02±0.101,但在4小时后出现第二个峰值3.23±0.121(p<0.01)。输注后24小时,与输注前值相比,血浆容量增加了4.8%。血浆容量的第二次增加无法用羟乙基淀粉的总浓度来解释,因为后者持续下降。血浆容量的增加伴随着平均分子量(-Mw和-Mn)的降低。有人认为,血清淀粉酶通过降解羟乙基淀粉产生小的渗透活性分子,从而导致血浆容量增加。输注羟乙基淀粉后12 - 24小时,血清淀粉酶比基础值高出两倍多。这是由一种不易消除的高分子羟乙基淀粉 - 淀粉酶复合物的形成引起的。当对血容量正常的患者重复给予羟乙基淀粉时,血浆容量的第二次增加应被视为急性血容量过多的可能原因。对于心肌功能不全的患者尤其如此。